Published in Mol Cell Proteomics on June 14, 2010
Mass spectrometry accelerates membrane protein analysis. Trends Biochem Sci (2011) 1.24
Personal genomes, quantitative dynamic omics and personalized medicine. Quant Biol (2013) 0.98
The kidney transcriptome and proteome defined by transcriptomics and antibody-based profiling. PLoS One (2014) 0.87
A reference map of the membrane proteome of Enterococcus faecalis. Proteomics (2011) 0.81
Protein-centric N-glycoproteomics analysis of membrane and plasma membrane proteins. J Proteome Res (2014) 0.77
Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery. Front Biol (Beijing) (2012) 0.77
Molecular Signatures of Membrane Protein Complexes Underlying Muscular Dystrophy. Mol Cell Proteomics (2016) 0.76
Less is More: Membrane Protein Digestion Beyond Urea-Trypsin Solution for Next-level Proteomics. Mol Cell Proteomics (2015) 0.75
Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions. J Immunol Res (2017) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics (2002) 30.58
Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01
Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem (1981) 26.33
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20
Correlation between protein and mRNA abundance in yeast. Mol Cell Biol (1999) 16.95
Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum. J Cell Biol (1982) 14.41
Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol (1999) 12.42
Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. J Mol Biol (1992) 11.97
Molecular anatomy of a trafficking organelle. Cell (2006) 11.47
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67
A proteomic view of the Plasmodium falciparum life cycle. Nature (2002) 10.65
TopPred II: an improved software for membrane protein structure predictions. Comput Appl Biosci (1994) 10.03
Proteomic characterization of the human centrosome by protein correlation profiling. Nature (2003) 8.74
MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52
Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics (2005) 8.14
Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci (1998) 7.88
Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat Biotechnol (2003) 6.86
Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics (2005) 6.37
Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics (2005) 6.34
A method for the comprehensive proteomic analysis of membrane proteins. Nat Biotechnol (2003) 6.32
Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell (2006) 5.72
Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol (2001) 5.69
Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 5.25
Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal Chem (2004) 4.06
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Quantitative proteomics analysis of the secretory pathway. Cell (2006) 3.63
Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol (1983) 3.60
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics (2008) 3.51
Detecting differential and correlated protein expression in label-free shotgun proteomics. J Proteome Res (2006) 3.51
Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal Chem (2003) 3.33
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol (2006) 3.03
Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98
A correlation algorithm for the automated quantitative analysis of shotgun proteomics data. Anal Chem (2003) 2.89
The utility of ETD mass spectrometry in proteomic analysis. Biochim Biophys Acta (2006) 2.85
Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol (2009) 2.70
Integral and peripheral protein composition of the apical and basolateral membrane domains in MDCK cells. J Membr Biol (1989) 2.65
Decoding protein modifications using top-down mass spectrometry. Nat Methods (2007) 2.62
Tumour vascular targeting. Nat Rev Cancer (2005) 2.56
Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Anal Biochem (1986) 2.55
Global and site-specific quantitative phosphoproteomics: principles and applications. Annu Rev Pharmacol Toxicol (2009) 2.53
Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem (2002) 2.27
LSimpute: accurate estimation of missing values in microarray data with least squares methods. Nucleic Acids Res (2004) 2.22
Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome: a sweet tale. Mol Cell Proteomics (2006) 2.11
Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science (1996) 1.95
Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res (2003) 1.90
Quantitative proteomic analysis of Myc oncoprotein function. EMBO J (2002) 1.89
Optimization of mass spectrometry-compatible surfactants for shotgun proteomics. J Proteome Res (2007) 1.84
Proteomic analysis of integral plasma membrane proteins. Anal Chem (2004) 1.78
Caveolae: mining little caves for new cancer targets. Nat Rev Cancer (2003) 1.76
Membrane topology and insertion of membrane proteins: search for topogenic signals. Microbiol Mol Biol Rev (2000) 1.74
Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment. J Proteome Res (2006) 1.71
Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res (2008) 1.67
A statistical model for iTRAQ data analysis. J Proteome Res (2008) 1.67
Proteomic analysis of glycosylphosphatidylinositol-anchored membrane proteins. Mol Cell Proteomics (2003) 1.65
The topological analysis of integral cytoplasmic membrane proteins. J Membr Biol (1993) 1.63
Shotgun proteomics: tools for the analysis of complex biological systems. Curr Opin Mol Ther (2002) 1.57
Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis (1998) 1.52
Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics (2008) 1.50
New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis. Electrophoresis (1998) 1.49
In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem (1998) 1.48
Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46
Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. Anal Chem (2003) 1.45
Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43
Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein Sci (1997) 1.40
Albumin interacts specifically with a 60-kDa microvascular endothelial glycoprotein. Proc Natl Acad Sci U S A (1988) 1.38
Specific albumin binding to microvascular endothelium in culture. Am J Physiol (1988) 1.37
Peptide sequencing and characterization of post-translational modifications by enhanced ion-charging and liquid chromatography electron-transfer dissociation tandem mass spectrometry. Anal Chem (2007) 1.35
Coating cells with colloidal silica for high yield isolation of plasma membrane sheets and identification of transmembrane proteins. J Biol Chem (1983) 1.33
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat Methods (2005) 1.32
A detergent- and cyanogen bromide-free method for integral membrane proteomics: application to Halobacterium purple membranes and the human epidermal membrane proteome. Proteomics (2004) 1.31
Tags for the stable isotopic labeling of carbohydrates and quantitative analysis by mass spectrometry. Anal Chem (2007) 1.27
Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties. Electrophoresis (2000) 1.25
Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics (2007) 1.24
gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol (1992) 1.24
Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene (2009) 1.24
Shotgun analysis of integral membrane proteins facilitated by elevated temperature. Anal Chem (2007) 1.22
Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome. Mol Cell Proteomics (2008) 1.20
Directed sample interrogation utilizing an accurate mass exclusion-based data-dependent acquisition strategy (AMEx). J Proteome Res (2009) 1.18
Use of magnetic beads with immobilized monoclonal antibodies for isolation of highly pure plasma membranes. Electrophoresis (2006) 1.17
IDAWG: Metabolic incorporation of stable isotope labels for quantitative glycomics of cultured cells. J Proteome Res (2009) 1.15
The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis. Cancer Res (2007) 1.14
Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs. Eur J Cell Biol (1992) 1.12
Shedding & shaving: disclosure of proteomic expressions on a bacterial face. Proteomics (2008) 1.09
Biotinylation reagents for the study of cell surface proteins. Proteomics (2008) 1.09
Affinity enrichment of plasma membrane for proteomics analysis. Electrophoresis (2003) 1.08
Photocrosslinking and click chemistry enable the specific detection of proteins interacting with phospholipids at the membrane interface. Chem Biol (2009) 1.08
Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells. Proteomics (2008) 1.06
Zooming in: fractionation strategies in proteomics. Proteomics (2004) 1.06
Amino acid-coded tagging approaches in quantitative proteomics. Expert Rev Proteomics (2007) 1.06
Protein cleavage strategies for an improved analysis of the membrane proteome. Proteome Sci (2006) 1.06
Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques. Proteomics (2006) 1.05
Combined in-gel tryptic digestion and CNBr cleavage for the generation of peptide maps of an integral membrane protein with MALDI-TOF mass spectrometry. Biochim Biophys Acta (2002) 1.04
Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain. Brain Res Mol Brain Res (2003) 1.04
Basolateral plasma membranes of intestinal epithelial cells. Identification by lactoperoxidase-catalysed iodination and isolation after density perturbation with digitonin. Biochem J (1975) 1.02
Preparation of a high-performance multi-lectin affinity chromatography (HP-M-LAC) adsorbent for the analysis of human plasma glycoproteins. J Sep Sci (2008) 1.02
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01
Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98
Caveolae: mining little caves for new cancer targets. Nat Rev Cancer (2003) 1.76
Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol (2003) 1.47
Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46
Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43
Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol (2002) 1.21
Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.10
Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci U S A (2009) 1.00
Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99
Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium. Am J Physiol Heart Circ Physiol (2004) 0.97
Application of capture-recapture models to estimation of protein count in MudPIT experiments. Anal Chem (2006) 0.96
Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem (2009) 0.95
T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol (2010) 0.94
Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol (2009) 0.92
Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramide. J Biol Chem (2002) 0.90
Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res (2003) 0.90
Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine (2010) 0.90
Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex. J Am Chem Soc (2013) 0.89
Genomics and proteomics of lung disease: conference summary. Am J Physiol Lung Cell Mol Physiol (2007) 0.88
Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.86
Endothelin induces rapid, dynamin-mediated budding of endothelial caveolae rich in ET-B. J Biol Chem (2012) 0.84
Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res (2009) 0.83
Caveolae and cancer. Recent Results Cancer Res (2010) 0.82
Targeting and imaging signature caveolar molecules in lungs. Proc Am Thorac Soc (2009) 0.81
Chapter 8. Proteomic mapping of the vascular endothelium in vivo for vascular targeting. Methods Enzymol (2008) 0.79
Streamlining biomarker discovery. Nat Biotechnol (2011) 0.79
Laser-targeted photosensitizer-induced lung injury: noninvasive rat model of pulmonary infarction. Exp Lung Res (2011) 0.76
Range Charts for Agreement in Measurement Comparison Studies, With Application to Replicate Mass Spectrometry Experiments. J Proteomics Bioinform (2008) 0.76
Systems analysis of endothelial cell plasma membrane proteome of rat lung microvasculature. Proteome Sci (2011) 0.76
Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction. Am J Physiol Heart Circ Physiol (2013) 0.75
Tumor targeting, trifunctional dendritic wedge. Bioconjug Chem (2014) 0.75
Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector. Virol J (2010) 0.75